, Tracking Stock Market Picks
Enter Symbol:
Heron Therapeutics Inc. (HRTX) [hlAlert]

up 287.47 %

Heron Therapeutics Inc. (HRTX) rated Buy with price target $18 by Noble Financial

Posted on: Thursday,  Aug 7, 2014  12:00 AM ET by Noble Financial

Noble Financial rated Buy Heron Therapeutics Inc. (NASDAQ: HRTX) on 08/07/2014, when the stock price was $8.62. Since
then, Heron Therapeutics Inc. has gained 287.47% as of 01/19/2016's recent price of $33.40.
If you would have followed this Noble Financial's recommendation on HRTX, you would have gained 287.47% of your investment in 530 days.

A.P. Pharma, Inc. (A.P. Pharma) is a specialty pharmaceutical company focused on developing pharmaceutical products using its Biochronomer polymer-based drug delivery technology. The Company?s primary focus is on its lead product candidate, APF530, which completed a pivotal Phase III clinical trial for the prevention of chemotherapy-induced nausea and vomiting (CINV) during the year ended December 31, 2008. APF530 is designed to prevent CINV for at least five days and contains granisetron, a drug approved for the prevention of CINV. In addition to its lead drug candidate, A.P. Pharma has a pipeline of other product candidates that use its Biochronomer technology. One of these, APF112, incorporates the local anesthetic, mepivacaine. It is designed to provide up to 36 hours of post-surgical pain relief and to minimize the use of morphine-like drugs, or opiates, which are used in post-surgical pain management.

A clear and concise focus. Identifying the emerging small or micro cap company. Recognizing the entrepreneurial character and organizational commitment of its executives and employees. Observing unstoppable drive to exploit opportunities while tackling obstacles. Understanding the company's essential products, services and technologies. Following only those who deserve our attention.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/7/2014 12:00 AM Buy
8.62 18.00
as of 10/17/2014
1 Week up  5.23 %
1 Month down  -18.77 %
3 Months down  -13.68 %
1 YTD down  -13.68 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy